Clinical Trials Directory

Trials / Completed

CompletedNCT06378853

Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients

Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients Based on Body Compositions Measured by 3D CT Scan and Hematological Indicators

Status
Completed
Phase
Study type
Observational
Enrollment
548 (actual)
Sponsor
Jinling Hospital, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

By evaluating the nutritional status of patients with pancreatic ductal adenocarcinoma (PDAC) admitted to Jinling Hospital, collecting relevant clinical data. we aim to conduct correlation analysis with patient clinical information, such as survival time, hospitalization time, nutritional status, hematological indicators, etc., in order to reveal the prognostic factors for overall survival and postoperative complications of PDAC patients.

Detailed description

Personalized and accurate survival risk prognostication remains a significant challenge in pancreatic ductal adenocarcinoma (PDAC), despite extensive research on prognostic and predictive markers. Patients with PDAC are prone to muscle loss, fat consumption, and malnutrition, which is associated with inferior outcomes. This study investigated the use of three-dimensional (3D) anthropometric parameters derived from computed tomography (CT) scans and hematological indicators in relation to overall survival (OS) outcomes and postoperative complications in PDAC patients. A retrospective analysis was conducted on patients with PDAC, all of whom had undergone pretreatment abdomen-pelvis CT scans. Automatic 3D measurements of subcutaneous and visceral fat volume, skeletal muscle volume, and skeletal muscle density (SMD) were assessed at the L3 vertebral level by an artificial intelligence assisted diagnosis system (HY Medical). Various indicators including TyG-BMI, nutritional indicators \[geriatric nutritional risk index (GNRI) and prealbumin\], and inflammation indicators \[(C-reactive protein (CRP) and neutrophil to lymphocyte ratio (NLR)\] were also recorded.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2019-01-01
Primary completion
2023-12-31
Completion
2024-02-28
First posted
2024-04-23
Last updated
2024-04-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06378853. Inclusion in this directory is not an endorsement.